Target Price | $15.50 |
Price | $5.29 |
Potential |
193.01%
register free of charge
|
Number of Estimates | 6 |
6 Analysts have issued a price target Fennec Pharmaceuticals Inc. 2025 .
The average Fennec Pharmaceuticals Inc. target price is $15.50.
This is
193.01%
register free of charge
$22.00
315.88%
register free of charge
$13.00
145.75%
register free of charge
|
|
A rating was issued by 6 analysts: 6 Analysts recommend Fennec Pharmaceuticals Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Fennec Pharmaceuticals Inc. stock has an average upside potential 2025 of
193.01%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 21.25 | 50.43 |
1,279.87% | 137.34% | |
EBITDA Margin | -60.09% | 23.79% |
95.90% | 139.59% | |
Net Margin | -77.17% | 6.05% |
95.17% | 107.84% |
6 Analysts have issued a sales forecast Fennec Pharmaceuticals Inc. 2024 . The average Fennec Pharmaceuticals Inc. sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Fennec Pharmaceuticals Inc. 2024 . The average Fennec Pharmaceuticals Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 Fennec Pharmaceuticals Inc. Analysts have issued a net profit forecast 2024. The average Fennec Pharmaceuticals Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.60 | 0.11 |
33.33% | 118.33% | |
P/E | 47.37 | |
EV/Sales | 2.61 |
6 Analysts have issued a Fennec Pharmaceuticals Inc. forecast for earnings per share. The average Fennec Pharmaceuticals Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Fennec Pharmaceuticals Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Fennec Pharmaceuticals Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.